Keyword: R&D

News

Advanced Enzyme Technologies Buys Evoxx

03.08.2017 - Indian enzyme manufacturer Advanced Enzyme Technologies has announced it will acquire all of German industrial biotech company Evoxx Technologies for €7.65 million in a bid to...

News

Merck KGaA Opens Applications Lab in Shanghai

01.08.2017 - German pharmaceuticals, chemicals and life sciences group Merck has opened a new application laboratory for its Performance Materials business sector in Shanghai, China. The...

News

Eli Lilly and Nektar Develop Autoimmune Therapy

31.07.2017 - US pharma companies Eli Lilly and Nektar Therapeutics have signed an agreement to jointly develop the latter’s novel immunotherapy, NKTR-358, which could potentially treat a number...

News

FDA Approves New Breast Cancer Treatment

19.07.2017 - The US Food and Drug Administration (FDA) has approved Nerlynx (neratinib), made by Puma Biotechnology for the extended adjuvant treatment of early-stage, HER2-positive breast...

News

Celgene to Buy into China’s BeiGene

13.07.2017 - US biopharmaceutical company Celgene has agreed to buy a stake in China’s BeiGene and help to develop and commercialize that company’s investigational treatment for tumor cancers...

News

Merck KGaA and iOnctura in new JV

05.07.2017 - Merck Ventures, the strategic investment arm of German pharmaceuticals and life sciences group Merck KGaA, has created immuno-oncology company iOnctura. Based in Geneva...

News

Bayer and Sumitomo in Fungicides Collaboration

29.06.2017 - Bayer and Sumitomo Chemical have agreed to cooperate in developing new fungicides aimed at controlling soybean diseases in Brazil. Financial details of the partnership were not...

News

Parexel International Taken by Pamplona

22.06.2017 - US drug development company Parexel International is being acquired by private equity group Pamplona Capital Management in a deal valued at approximately $5 billion, including debt...